Badr Al-Bawardy is an expert in Gastroenterology at King Faisal Specialist Hospital & Research Centre (Saudi Arabia). As of October 2026, ScienceLeadR ranks Badr Al-Bawardy in the top 1% of experts worldwide for Gastroenteritis, and in the top 1% of experts in Saudi Arabia for Colitis and Inflammatory Bowel Diseases. Badr Al-Bawardy has authored 205 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 914 (community average: 125). How the SLR is computed.

LeadR Profile

914 ScienceLeadR Reputation 914
Network Map

Gastroenterology

Subspecialties: Hepatology - Public Health - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2013 - 2026

Source: PubMed

Yale School of Medicine

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Epidemiology of inflammatory bowel disease in the Middle East and North Africa: a multinational, tertiary care registry (MIRAGE) study.
PMID 42832339 — registries, epidemiology, colitis, phenotype, multiple chronic conditions, inflammatory bowel diseases, therapeutics, tertiary healthcare, smoking, colitis, ulcerative
J Crohns Colitis20260
Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipeline.
PMID 42660189 — cells, receptors, tumor necrosis factor, member 25, antibodies, crohn disease, inflammatory bowel diseases, precision medicine, therapeutics, biological therapy, tissues, colitis, ulcerative
Inflamm Bowel Dis20260
Postoperative Complications Associated with Advanced Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
PMID 42606796 — abdominal abscess, equipment and supplies, pharmaceutical preparations, drug therapy, inflammatory bowel diseases, diagnosis, therapeutics, postoperative complications
Adv Ther20260
Global phenotypic similarity in inflammatory bowel disease: the Eastern Mediterranean region perspective.
PMID 42309522 — inflammatory bowel diseases
J Crohns Colitis20260
Mortality and Infectious Adverse Events in Neutropenic Patients Undergoing Gastrointestinal Endoscopic Procedures: A Systematic Review and Meta-Analysis.
PMID 42293779 — bacteremia, mortality, safety, drug-related side effects and adverse reactions, endoscopy, infections
Gastro Hep Adv20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Active not recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map